Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 49 Show results per page	View Search Criteria \| Help With Results

Last Modified: 10/1/1990


1.		Phase III Randomized Study of Chemotherapy with MTX vs EDAM (a New MTX Analogue) in Patients with Advanced Squamous Cell Carcinoma of the Head and Neck (Summary Last Modified 10/90)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				75 and under								EORTC-24872

Last Modified: 4/1/1991


2.		Phase III Comparison of MITO/VBL with vs without EDAM in the Treatment of Stage III/IV non-Small Cell Lung Cancer (Summary Last Modified 04/91)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 and over								CG-10-EDAM NCI-V90-0130

Last Modified: 6/1/1989


3.		Phase I/II Pilot Study of EMV (EDAM/Mitomycin/Vinblastine) in Patients with Stage III/IV non-Small Cell Lung Cancer (Summary Last Modified 06/89)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Closed				18 and over								MSKCC-87053A NCI-V88-0577

Last Modified: 12/1/2001


4.		Phase I/II Study of Edatrexate in Advanced Breast Cancer and Other Advanced Malignancies (Summary Last Modified 12/2001)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Completed				18 and over				NCI				MAYO-CCG-921 NCI-T92-0171O, T92-0171

Last Modified: 7/1/1994


5.		Phase II Study of EDAM Administered Weekly for Advanced or Recurrent Squamous Cell Carcinoma of the Cervix (Summary Last Modified 07/94)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				MSKCC-93149 NCI-T94-0027D, T94-0027

Last Modified: 10/1/2001


6.		Phase II Study of EDAM for Advanced Soft Tissue Sarcoma (Summary Last Modified 10/2001)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				E-3793 E3793

Last Modified: 1/15/2007


7.		Phase II Study of Edatrexate/Vinblastine/Doxorubicin/Cisplatin with G-CSF in Advanced non-Small Cell Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				NCCTG-952452 NCCTG-95-24-52

Last Modified: 9/1/1991


8.		Phase II Study of EDAM in Patients with Metastatic or Locally Inoperable Breast Cancer (Summary Last Modified 09/91)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				CAN-NCIC-IND60 NCI-T90-0128O, T90-0128, IND60

Last Modified: 6/1/1988


9.		Phase II Chemotherapy with EDAM in Patients with Stage IIIB/IV non-Small Cell Lung Cancer (Summary Last Modified 06/88)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over								MDA-DM-87086 NCI-V88-0339

Last Modified: 11/1/1991


10.		Phase II Chemotherapy with EDAM in Patients with Advanced Sarcoma (Summary Last Modified 11/91)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				MSKCC-87046A1 NCI-T89-0134D, T89-0134

Select All on One Page


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute